Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules

Purpose To determine a novel quantitative index, residual vital ratio(RVR) by contrast-enhanced ultrasound(CEUS) with conventional Ultrasound(US), to early predict nodule regrowth after radiofrequency ablation (RFA)for benign thyroid nodules. Methods This retrospective study evaluated 186 patients w...

Full description

Bibliographic Details
Main Authors: Lin Yan, Yukun Luo, Fang Xie, Mingbo Zhang, Jing Xiao
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:http://dx.doi.org/10.1080/02656736.2020.1825835
id doaj-be9e5502bc014c1886fd2cb7d94548e1
record_format Article
spelling doaj-be9e5502bc014c1886fd2cb7d94548e12021-08-09T15:50:03ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572020-01-013711139114810.1080/02656736.2020.18258351825835Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodulesLin Yan0Yukun Luo1Fang Xie2Mingbo Zhang3Jing Xiao4Department of Ultrasound, First Medical Center, Chinese PLA General HospitalDepartment of Ultrasound, First Medical Center, Chinese PLA General HospitalDepartment of Ultrasound, First Medical Center, Chinese PLA General HospitalDepartment of Ultrasound, First Medical Center, Chinese PLA General HospitalDepartment of Ultrasound, First Medical Center, Chinese PLA General HospitalPurpose To determine a novel quantitative index, residual vital ratio(RVR) by contrast-enhanced ultrasound(CEUS) with conventional Ultrasound(US), to early predict nodule regrowth after radiofrequency ablation (RFA)for benign thyroid nodules. Methods This retrospective study evaluated 186 patients with 206 benign thyroid nodules underwent RFA. Patients were followed at 1, 3, 6, 12 months and every 12 months thereafter by conventional US, CEUS and clinical evaluation. RVR was defined as the initial ratio of residual vital volume to the total volume calculated by CEUS and conventional US at the first follow-up period after RFA. The relationship between RVR and regrowth was investigated. Results The mean volume of thyroid nodules was 10.09 ± 12.90 ml (range 0.40–71.39 ml), which decreased significantly to 2.33 ± 4.65 ml (range 0–36.75 ml) (p < .001) after a mean follow-up time of 22.50 ± 13.29 months (range 6–68 months) with a mean VRR as 85.26 ± 15.02% (range 32.23–100%). The overall incidence of regrowth was 12.62% (26/206) and the mean timing of regrowth was 20.77 ± 12.03 months (range 6–48 months). Multivariate logistic regression revealed that RVR (OR = 1.050, 95%CI 1.025–1.075), initial volume(OR = 1.033, 95%CI 1.000–1.066), location close to critical structures (OR = 5.967, 95%CI 1.898–18.760) and vascularity (OR = 2.216, 95%CI 1.185–4.143) were independent factors associated with regrowth. According to receiver-operating characteristic curve, the area under curve for RVR to regrowth was 0.819 (95% CI 0.740–0.897, p < .001) with the optimal cutoff value of 44.5% (sensitivity 80.8%, specificity 74.7%). Conclusion RVR was not only an independent factor but also an early quantitative predictor for regrowth. If RVR was larger than 44.5%, the nodule tended to regrowth in the follow-up.http://dx.doi.org/10.1080/02656736.2020.1825835radiofrequency ablationthyroid noduleregrowthresidual vital ratiocontrast-enhancement ultrasound
collection DOAJ
language English
format Article
sources DOAJ
author Lin Yan
Yukun Luo
Fang Xie
Mingbo Zhang
Jing Xiao
spellingShingle Lin Yan
Yukun Luo
Fang Xie
Mingbo Zhang
Jing Xiao
Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules
International Journal of Hyperthermia
radiofrequency ablation
thyroid nodule
regrowth
residual vital ratio
contrast-enhancement ultrasound
author_facet Lin Yan
Yukun Luo
Fang Xie
Mingbo Zhang
Jing Xiao
author_sort Lin Yan
title Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules
title_short Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules
title_full Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules
title_fullStr Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules
title_full_unstemmed Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules
title_sort residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules
publisher Taylor & Francis Group
series International Journal of Hyperthermia
issn 0265-6736
1464-5157
publishDate 2020-01-01
description Purpose To determine a novel quantitative index, residual vital ratio(RVR) by contrast-enhanced ultrasound(CEUS) with conventional Ultrasound(US), to early predict nodule regrowth after radiofrequency ablation (RFA)for benign thyroid nodules. Methods This retrospective study evaluated 186 patients with 206 benign thyroid nodules underwent RFA. Patients were followed at 1, 3, 6, 12 months and every 12 months thereafter by conventional US, CEUS and clinical evaluation. RVR was defined as the initial ratio of residual vital volume to the total volume calculated by CEUS and conventional US at the first follow-up period after RFA. The relationship between RVR and regrowth was investigated. Results The mean volume of thyroid nodules was 10.09 ± 12.90 ml (range 0.40–71.39 ml), which decreased significantly to 2.33 ± 4.65 ml (range 0–36.75 ml) (p < .001) after a mean follow-up time of 22.50 ± 13.29 months (range 6–68 months) with a mean VRR as 85.26 ± 15.02% (range 32.23–100%). The overall incidence of regrowth was 12.62% (26/206) and the mean timing of regrowth was 20.77 ± 12.03 months (range 6–48 months). Multivariate logistic regression revealed that RVR (OR = 1.050, 95%CI 1.025–1.075), initial volume(OR = 1.033, 95%CI 1.000–1.066), location close to critical structures (OR = 5.967, 95%CI 1.898–18.760) and vascularity (OR = 2.216, 95%CI 1.185–4.143) were independent factors associated with regrowth. According to receiver-operating characteristic curve, the area under curve for RVR to regrowth was 0.819 (95% CI 0.740–0.897, p < .001) with the optimal cutoff value of 44.5% (sensitivity 80.8%, specificity 74.7%). Conclusion RVR was not only an independent factor but also an early quantitative predictor for regrowth. If RVR was larger than 44.5%, the nodule tended to regrowth in the follow-up.
topic radiofrequency ablation
thyroid nodule
regrowth
residual vital ratio
contrast-enhancement ultrasound
url http://dx.doi.org/10.1080/02656736.2020.1825835
work_keys_str_mv AT linyan residualvitalratiopredictingregrowthafterradiofrequencyablationforbenignthyroidnodules
AT yukunluo residualvitalratiopredictingregrowthafterradiofrequencyablationforbenignthyroidnodules
AT fangxie residualvitalratiopredictingregrowthafterradiofrequencyablationforbenignthyroidnodules
AT mingbozhang residualvitalratiopredictingregrowthafterradiofrequencyablationforbenignthyroidnodules
AT jingxiao residualvitalratiopredictingregrowthafterradiofrequencyablationforbenignthyroidnodules
_version_ 1721213809265213440